Peer-Reviewed Articles
In Practice With Immunotherapy: Q&A With Jedd D. Wolchok, MD, PhD
Management of Hepatocellular Cancer
Bromodomain Inhibitor Shows Activity in Hematologic Malignancies
Immune Checkpoint Inhibitors for Renal Cell Carcinoma
Soft Tissue Sarcomas: Emerging and Novel Concepts
Androgen-Targeting Therapies Increasing in CRPC
Immunotherapies in CRPC: Progress Evident but Not Without Challenges
NCCN Guidelines Include Obinutuzumab in CLL
Mutant-Specific Epidermal Growth Factor Receptor Inhibitors